Cargando…
The Effects of Commercially Available Syzygium aromaticum, Anethum graveolens, Lactobacillus acidophilus LB, and Zinc as Alternatives Therapy in Experimental Mice Challenged with Cryptosporidium parvum
BACKGROUND: Waterborne cryptosporidiosis is the second cause of diarrhea in young children and immunocompromised hosts after rotavirus. Except for nitazoxanide (NTZ), there is no accredited cryptosporidiosis treatment to date. Therefore, there is an urgent need to find an effective and safe treatmen...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789248/ https://www.ncbi.nlm.nih.gov/pubmed/35087280 http://dx.doi.org/10.2147/IDR.S345789 |
_version_ | 1784639726325596160 |
---|---|
author | Gaber, Mona Galal, Lamia Ahmed A Farrag, Haiam Mohamed Mahmoud Badary, Dalia M Alkhalil, Samia S Elossily, Nahed |
author_facet | Gaber, Mona Galal, Lamia Ahmed A Farrag, Haiam Mohamed Mahmoud Badary, Dalia M Alkhalil, Samia S Elossily, Nahed |
author_sort | Gaber, Mona |
collection | PubMed |
description | BACKGROUND: Waterborne cryptosporidiosis is the second cause of diarrhea in young children and immunocompromised hosts after rotavirus. Except for nitazoxanide (NTZ), there is no accredited cryptosporidiosis treatment to date. Therefore, there is an urgent need to find an effective and safe treatment for cryptosporidiosis. This study aimed to investigate the possible anti-protozoal effects of Syzygium aromaticum (clove) oil, Anethum graveolens (dill) seeds oil, Lactobacillus acidophilus LB, and zinc against Cryptosporidium parvum in comparison to NTZ. METHODS: Besides the negative control, mice from six experimental groups (T1–T6) were infected with Cryptosporidium parvum oocysts. On the seventh day post-infection (PID), mice from five groups were treated for 8 consecutive days with NTZ, clove oil, dill seed oil, Lactobacillus acidophilus LB, and zinc commercial forms (T2–T5). Oocysts shedding rate, differences of mice body weight, serum IL10, and TNF-α, cryptosporidial antigen, and cd3 at the intestinal mucosa were evaluated at the end of the experiment. RESULTS: The mean of the C. parvum oocysts’ shedding rate was significantly lower in all treated groups than in the non-treated group. The oocysts reduction rate was the highest in zinc-treated mice (98.3%), Lactobacillus acidophilus LB and dill-treated groups (95.77%), and the NTZ-treated group (91.55%). Clove oil was the least effective, with a 74.65% reduction rate. Excluding the clove oil-treated group, immunohistochemical analysis revealed the clearance of the Cryptosporidium antigen in the intestinal tissue in all treated groups. CONCLUSION: The study has provided a rational basis for using these safe, cheap, and commercially available alternatives in treating cryptosporidiosis combined with NTZ. |
format | Online Article Text |
id | pubmed-8789248 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-87892482022-01-26 The Effects of Commercially Available Syzygium aromaticum, Anethum graveolens, Lactobacillus acidophilus LB, and Zinc as Alternatives Therapy in Experimental Mice Challenged with Cryptosporidium parvum Gaber, Mona Galal, Lamia Ahmed A Farrag, Haiam Mohamed Mahmoud Badary, Dalia M Alkhalil, Samia S Elossily, Nahed Infect Drug Resist Original Research BACKGROUND: Waterborne cryptosporidiosis is the second cause of diarrhea in young children and immunocompromised hosts after rotavirus. Except for nitazoxanide (NTZ), there is no accredited cryptosporidiosis treatment to date. Therefore, there is an urgent need to find an effective and safe treatment for cryptosporidiosis. This study aimed to investigate the possible anti-protozoal effects of Syzygium aromaticum (clove) oil, Anethum graveolens (dill) seeds oil, Lactobacillus acidophilus LB, and zinc against Cryptosporidium parvum in comparison to NTZ. METHODS: Besides the negative control, mice from six experimental groups (T1–T6) were infected with Cryptosporidium parvum oocysts. On the seventh day post-infection (PID), mice from five groups were treated for 8 consecutive days with NTZ, clove oil, dill seed oil, Lactobacillus acidophilus LB, and zinc commercial forms (T2–T5). Oocysts shedding rate, differences of mice body weight, serum IL10, and TNF-α, cryptosporidial antigen, and cd3 at the intestinal mucosa were evaluated at the end of the experiment. RESULTS: The mean of the C. parvum oocysts’ shedding rate was significantly lower in all treated groups than in the non-treated group. The oocysts reduction rate was the highest in zinc-treated mice (98.3%), Lactobacillus acidophilus LB and dill-treated groups (95.77%), and the NTZ-treated group (91.55%). Clove oil was the least effective, with a 74.65% reduction rate. Excluding the clove oil-treated group, immunohistochemical analysis revealed the clearance of the Cryptosporidium antigen in the intestinal tissue in all treated groups. CONCLUSION: The study has provided a rational basis for using these safe, cheap, and commercially available alternatives in treating cryptosporidiosis combined with NTZ. Dove 2022-01-20 /pmc/articles/PMC8789248/ /pubmed/35087280 http://dx.doi.org/10.2147/IDR.S345789 Text en © 2022 Gaber et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Gaber, Mona Galal, Lamia Ahmed A Farrag, Haiam Mohamed Mahmoud Badary, Dalia M Alkhalil, Samia S Elossily, Nahed The Effects of Commercially Available Syzygium aromaticum, Anethum graveolens, Lactobacillus acidophilus LB, and Zinc as Alternatives Therapy in Experimental Mice Challenged with Cryptosporidium parvum |
title | The Effects of Commercially Available Syzygium aromaticum, Anethum graveolens, Lactobacillus acidophilus LB, and Zinc as Alternatives Therapy in Experimental Mice Challenged with Cryptosporidium parvum |
title_full | The Effects of Commercially Available Syzygium aromaticum, Anethum graveolens, Lactobacillus acidophilus LB, and Zinc as Alternatives Therapy in Experimental Mice Challenged with Cryptosporidium parvum |
title_fullStr | The Effects of Commercially Available Syzygium aromaticum, Anethum graveolens, Lactobacillus acidophilus LB, and Zinc as Alternatives Therapy in Experimental Mice Challenged with Cryptosporidium parvum |
title_full_unstemmed | The Effects of Commercially Available Syzygium aromaticum, Anethum graveolens, Lactobacillus acidophilus LB, and Zinc as Alternatives Therapy in Experimental Mice Challenged with Cryptosporidium parvum |
title_short | The Effects of Commercially Available Syzygium aromaticum, Anethum graveolens, Lactobacillus acidophilus LB, and Zinc as Alternatives Therapy in Experimental Mice Challenged with Cryptosporidium parvum |
title_sort | effects of commercially available syzygium aromaticum, anethum graveolens, lactobacillus acidophilus lb, and zinc as alternatives therapy in experimental mice challenged with cryptosporidium parvum |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789248/ https://www.ncbi.nlm.nih.gov/pubmed/35087280 http://dx.doi.org/10.2147/IDR.S345789 |
work_keys_str_mv | AT gabermona theeffectsofcommerciallyavailablesyzygiumaromaticumanethumgraveolenslactobacillusacidophiluslbandzincasalternativestherapyinexperimentalmicechallengedwithcryptosporidiumparvum AT galallamiaahmeda theeffectsofcommerciallyavailablesyzygiumaromaticumanethumgraveolenslactobacillusacidophiluslbandzincasalternativestherapyinexperimentalmicechallengedwithcryptosporidiumparvum AT farraghaiammohamedmahmoud theeffectsofcommerciallyavailablesyzygiumaromaticumanethumgraveolenslactobacillusacidophiluslbandzincasalternativestherapyinexperimentalmicechallengedwithcryptosporidiumparvum AT badarydaliam theeffectsofcommerciallyavailablesyzygiumaromaticumanethumgraveolenslactobacillusacidophiluslbandzincasalternativestherapyinexperimentalmicechallengedwithcryptosporidiumparvum AT alkhalilsamias theeffectsofcommerciallyavailablesyzygiumaromaticumanethumgraveolenslactobacillusacidophiluslbandzincasalternativestherapyinexperimentalmicechallengedwithcryptosporidiumparvum AT elossilynahed theeffectsofcommerciallyavailablesyzygiumaromaticumanethumgraveolenslactobacillusacidophiluslbandzincasalternativestherapyinexperimentalmicechallengedwithcryptosporidiumparvum AT gabermona effectsofcommerciallyavailablesyzygiumaromaticumanethumgraveolenslactobacillusacidophiluslbandzincasalternativestherapyinexperimentalmicechallengedwithcryptosporidiumparvum AT galallamiaahmeda effectsofcommerciallyavailablesyzygiumaromaticumanethumgraveolenslactobacillusacidophiluslbandzincasalternativestherapyinexperimentalmicechallengedwithcryptosporidiumparvum AT farraghaiammohamedmahmoud effectsofcommerciallyavailablesyzygiumaromaticumanethumgraveolenslactobacillusacidophiluslbandzincasalternativestherapyinexperimentalmicechallengedwithcryptosporidiumparvum AT badarydaliam effectsofcommerciallyavailablesyzygiumaromaticumanethumgraveolenslactobacillusacidophiluslbandzincasalternativestherapyinexperimentalmicechallengedwithcryptosporidiumparvum AT alkhalilsamias effectsofcommerciallyavailablesyzygiumaromaticumanethumgraveolenslactobacillusacidophiluslbandzincasalternativestherapyinexperimentalmicechallengedwithcryptosporidiumparvum AT elossilynahed effectsofcommerciallyavailablesyzygiumaromaticumanethumgraveolenslactobacillusacidophiluslbandzincasalternativestherapyinexperimentalmicechallengedwithcryptosporidiumparvum |